Tăng đường huyết mãn tính và khả dụng nitric oxide đóng vai trò chủ chốt trong các biến đổi mạch máu có khả năng gây xơ vữa

Johansen JS, Harris AK, Rychly DJ, Ergul A (2005) Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol 4:5 Laakso M (1999) Hyperglycaemia and cardiovascular disease in type 2 diabetes. Diabetes 48:937–942 Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease. JAMA 241:2035–2058 Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615–1625 Balletshofer BM, Rittig K, Enderle MD, Volk A, Maerker E, Jacob S, Matthaei S, Rett K, Haring HU (2000) Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 101:1780–1784 Pieper GM, Dembny K, Siebeneich W (1998) Long-term treatment in vivo with NOX-101, a scavenger of nitric oxide, prevents diabetes-induced endothelial dysfunction. Diabetologia 41:1220–1226 Pricci F, Leto G, Amadio L, Iacobini C, Cordone S, Catalano S, Zicari A, Sorcini M, Di Mario U, Pugliese G (2003) Oxidative stress in diabetes-induced endothelial dysfunction. Involvement of nitric oxide and protein Kinase C. Free Radic Biol Med 35:683–694 UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood- glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853 Lopez-Garcia E, Hu FB (2004) Nutrition and the endothelium. Curr Diabetes Rep 4:253–259 Brasier AR, Recinos A, Eledrisi MS (2002) Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol 22:1257–1266 Calles-Escandon J, Cipolla M (2001) Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 22:36–52 De Meyer GR, Herman AG (1997) Vascular endothelial dysfunction. Prog Cardiovasc Dis 39:325–342 Plante GE (2002) Vascular response to stress in health and disease. Metabolism 51:25–30 Alderton WK, Cooper CE, Knowles RG (2001) Nitric oxide synthases: structure, function and inhibition. Biochem J 357:593–615 Papapetropoulos A, Rudic RD, Sessa WC (1999) Molecular control of nitric oxide synthases in the cardiovascular system. Cardiovasc Res 43:509–520 Li H, Forstermann U (2000) Nitric oxide in the pathogenesis of vascular disease. J Pathol 190:244–254 Kibbe M, Billiar T, Tzeng E (1999) Inducible nitric oxide synthase and vascular injury. Cardiovasc Res 43:650–657 Andrew P, Mayer B (1999) Enzymatic function of nitric oxide synthases. Cardiovasc Res 43:521–531 Harrison DG (1997) Nitric oxide and nitric oxide synthases—cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100(9):2153–2157 Di Fulvio P, Formoso G, Di Silvestre S, Di Tomo P, Giardinelli A, La Sorda R, Di Pietro N, Piantelli M, Consoli A, Pandolfi A (2006) Increased vascular wall endothelial nitric oxide synthase (eNOS) levels in umbilical cords from gestational diabetic women. Atherosclerosis 14(W2):5 (Abstract) Pandolfi A, Grilli A, Cilli C, Patruno A, Giaccari A, Di Silvestre S, De Lutiis MA, Pellegrini G, Capani F, Consoli A, Felaco M (2003) Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: association with increased nitric oxide synthase expression and superoxide anion generation. J Cell Physiol 196:378–385 Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, King GL, LoGerfo FW, Horton ES, Veves A (1999) Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 48:1856–1862 Jaap AJ, Shore AC, Tooke JE (1997) Relationship of insulin resistance to microvascular dysfunction in subjects with fasting hyperglycaemia. Diabetologia 40:238–243 Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD (1996) Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97:2601–2610 Vehkavaara S, Seppala-Lindroos A, Westerbacka J, Groop PH, Yki-Jarvinen H (1999) In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. Diabetes Care 22:2055–2060 Sorescu D, Szocs K, Griendling KK (2001) NAD(P)H oxidases and their relevance to atherosclerosis. Trends Cardiovasc Med 11:124–131 Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, Griendling KK (2002) Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105:1429–1435 Warnholtz A, Nickenig G, Schultz E, Macharzina R, Bransen JH, Skatchkov M, Heitzer T, Stasch JP, Griendling KK, Harrison DG, Bohm M, Meinertz T, Munzel T (1999) Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 99:2027–2033 Cai H, Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87:840–844 Matsuoka H (2001) Endothelial dysfunction associated with oxidative stress in human. Diabetes Res Clin Pract 54:S65–S72 Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, Harrison DG (2001) Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103:1282–1288 Zou MH, Hou XY, Shi CM, Nagata D, Walsh K, Cohen RA (2002) Modulation by peroxynitrite of Akt- and AMP-activated kinase-dependent Ser1179 phosphorylation of endothelial nitric oxide synthase. J Biol Chem 277:35552–35557 Zou MH, Shi C, Cohen RA (2002) Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 109:817–826 Rask-Madsen C, King GL (2005) Proatherosclerotic mechanism involving protein kinase C in diabetes and insulin resistance. Arterioscler Thromb Vasc Biol 24:1542–1548 Mertens A, Holvoet P (2001) Oxidized LDL and HDL: antagonists in atherothrombosis. FASEB J 15:2073–2084 Hazell LJ, Arnold L, Flowers D, Waeg G, Malle E, Stocker R (1996) Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest 97:1535–1544 Podrez EA, Schmitt D, Hoff HF, Hazen SL (1999) Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest 103:1547–1560 Carpenter KL, Dennis IF, Challis IR, Osborn DP, Macphee CH, Leake DS, Arends MJ, Mitchinson MJ (2001) Inhibition of lipoprotein-associated phospholipase A2 diminishes the death-inducing effects of oxidised LDL on human monocyte-macrophages. FEBS Lett 505:357–363 Hanasaki K, Yamada K, Yamamoto S, Ishimoto Y, Saiga A, Ono T, Ikeda M, Notoya M, Kamitani S, Arita H (2002) Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation. Biol Chem 277:29116–29124 Reddy S, Hama S, Grijalva V, Hassan K, Mottahedeh R, Hough G, Wadleigh DJ, Navab M, Fogelman AM (2001) Mitogen-activated protein kinase phosphatase 1 activity is necessary for oxidized phospholipids to induce monocyte chemotactic activity in human aortic endothelial cells. J Biol Chem 276:17030–17035 Sonoki K, Yoshinari M, Iwase M, Ino K, Ichikawa K, Ohdo S, Higuchi S, Iida M (2002) Glycoxidized low-density lipoprotein enhances monocyte chemoattractant protein-1 mRNA expression in human umbilical vein endothelial cells: relation to lysophosphatidylcholine contents and inhibition by nitric oxide donor. Metabolism 51:1135–1142 Kita T, Kume N, Yokode M, Ishii K, Arai H, Horiuchi H, Moriwaki H, Minami M, Kataoka H, Wakatsuki Y (2000) Oxidized-LDL and atherosclerosis. Role of LOX-1. Ann N Y Acad Sci 902:95–100 Malden LT, Chait A, Raines EW, Ross R (1991) The influence of oxidatively modified low density lipoproteins on expression of platelet-derived growth factor by human monocyte-derived macrophages. J Biol Chem 266:13901–13907 Stiko-Rahm A, Hultgard-Nilsson A, strom J, Hamsten A, Nilsson J (1992) Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells. ArteriosclerThromb Vasc Biol 12:1099–1109 Zhao SP, Xu DY (2000) Oxidized lipoprotein(a) enhanced the expression of P-selectin in cultured human umbilical vein endothelial cells. Thromb Res 100:501–510 Zwijsen RM, Japenga SC, Heijen AM, van den Bros RC, Koeman JH (1992) Induction of platelet-derived growth factor chain A gene expression in human smooth muscle cells by oxidized low density lipoproteins. Biochem and Biophys Res Commun 186:1410–1416 Ananyeva NM, Tjurmin AV, Berliner JA, Chisolm GM, Liau G, Winkles JA, Haudenschild CC (1997) Oxidized LDL mediates the release of fibroblast growth factor-1. Arterioscler Thromb Vasc Biol 17:445–453 Chai YC, Binion DG, Chisolm GM (2000) Relationship of molecular structure to the mechanism of lysophospholipid-induced smooth muscle cell proliferation. Am J Physiol Heart Circ Physiol 279:H1830–H1838 Chai YC, Binion DG, Macklis R, Chilsom GM (2002) Smooth muscle cell proliferation induced by oxidized LDL-borne lysophosphatidylcholine. Evidence for FGF-2 release from cells not extracellular matrix. Vasc Pharmacol 38:229–237 Chai YC, Howe PH, Di Corleto PE, Chisolm GM (1996) Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2. J Biol Chem 271:17791–17797 Chisolm GM, Chai Y (2000) Regulation of cell growth by oxidized LDL. Free Radic Biol Med 28:1697–1707 Koba S, Pakala R, Watanabe T, Katagiri T, Benedict CR (2000) Synergistic interaction between thromboxane A2 and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferation. Prostaglandins Leukot Essent Fatty Acids 63:329–335 Price DT, Vita JA, Keaney JF Jr (2000) Redox control of vascular nitric oxide bioavailability. Antioxid Redox Signal 2:919–935 Vanhoutte PM (2001) Endothelium-derived free radicals: for worse and for better. J Clin Invest 107:23–25 Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, Tsuji H, Reaven GM, Cooke JP (2002) Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 106:987–992 Liao JK, Shin WS, Lee WY, Clark SL (1995) Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 270:319–324 Nuszkowski A, Grabner R, Marsche G, Unbehaun A, Malle E, Heller R (2001) Hypochlorite-modified low density lipoprotein inhibits nitric oxide synthesis in endothelial cells via an intracellular dislocalization of endothelial nitric-oxide synthase. J Biol Chem 276:14212–14221 Vergnani L, Hatrik S, Ricci F, Passaro A, Manzoli N, Zuliani G, Brovkovynch V, Fellin R, Malinski T (2000) Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production: key role of l-arginine availability. Circulation 101:1261–1266 Cui MZ, Penn MS, Chisolm GM (1999) Native and oxidized low density lipoprotein induction of tissue factor gene expression in smooth muscle cells is mediated by both Egr-1 and Sp1. J Biol Chem 274:32795–32802 Fei H, Berliner JA, Parhami F, Drake TA (1993) Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide. Arterioscler Thromb J Vasc Biol 13:1711–1717 Dichtl W, Stiko A, Eriksson P, Goncalves I, Calara F, Banfi C, Ares MP, Hamsten A, Nilsson J (1999) Oxidized LDL and lysophosphatidylcholine stimulate plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19:3025–3032 Ren S, Man RY, Angel A, Shen GX (1997) Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-1 in cultured vascular endothelial cells. Atherosclerosis 128:1–10 Koya D, King GL (1998) Proteinkinase C activation and development of diabetic complications. Diabetes 47:859–866 Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL (1994) Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 43:1122–1129 Feener EP, Xia P, Inoguchi T, Shiba T, Kunisaki M, King GL (1996) Role of protein kinase C in glucose- and angiotensin II-induced plasminogen activator inhibitor expression. Contrib Nephrol 118:180–187 Kuboki K, Jiang ZJ, Takahara N, Ha SW, Igarashi M, Yamauchi T, Feener EP, Herbert TP, Rhodes CJ, King GL (2000) Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 101:676–681 Pandolfi A, Iacovello L, Capani F, Vitacolonna E, Donati MB, Consoli A (1996) Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture. Diabetologia 39:1425–1431 Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A (2003) Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NADPH-oxidase activation. Diabetes 52:2795–2804 Quagliaro L, Piconi L, Assaloni R, Da Ros R, Maier A, Zuodar G, Ceriello A (2005) Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectine expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis 183:259–267 Ferre P (1999) Regulation of gene expression by glucose. The Proceedings of the nutrition Society 58:621–623 Stenina OI (2005) Regulation of vascular gene by glucose. Curr Pharm Des 11:2367–2381 Ginsberg HN (2000) Insulin resistance and cardiovascular disease. J Clin Invest 106:453–58 The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long- term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986 UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood- glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854–865 Wei M, Gaskill SP, Haffner SM, Stern MP (1998) Effect of diabetes and level of glycemia on all-cause and cardiovascular mortality. The san Antonio Heart Study. Diabetes Care 21:1167–1172 Ceriello A (2006) Oxidative stress and diabetes-associated complications. Endocr Pract 12:60–62 Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787–790 Ueda S, Yasunari K (2006) What we learnt from randomized clinical trials and cohort studies of antioxidant vitamin?: focus on vitamin E and cardiovascular disease. Curr Pharm Biotechnol 7:69–72 Stevens MJ (2005) Oxidative-nitrosative stress as a contributing factor to cardiovascular disease in subjects with diabetes. Curr Vasc Pharmacol 3:253–266 Wautier JL, Schmidt AM (2004) Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 95:233–238 Duraisamy Y, Slevin M, Smith N, Bailey J, Zweit J, Smith C, Ahmed N, Gaffney J (2001) Effect of glycation on basic fibroblast growth factor induced angiogenesis and activation of associated signal transduction pathways in vascular endothelial cells: possible relevance to wound healing in diabetes. Angiogenesis 4:277–288 Watala C, Gwozdzinski K, Pluskota E, Pietrucha T, Walkowiak B, Trojanowski Z, Cierniewski CS (1996) Diabetes mellitus alters the effect of peptide and protein ligands on membrane fluidity of blood platelets. Thromb Haemost 75:147–153 Zachara NE, Hart GW (2004) O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in responce to nutrition and stress. Biochim Biophys Acta 1673:13–28 Burt DJ, Gruden G, Thomas SM, Tutt P, Dell’Anna C, Viberti GC, Gnudi L (2003) P38 mitogen-activated protein kinase mediates hexosamine-induced TGFβ1 mRNA expression in human mesangial cells. Diabetologia 46:531–537 Han I, Oh ES, Kudlow JE (2000) Responsiveness to the state of O-linked N-acetylglucosamine modification of nuclear pore protein p62 to the extracellular glucose concentration. Biochem J 350:109–114 Sayeski PP, Kudlow JE (1996) Glucose metabolism to glucosamine is necessary for glucose stimulation of trasforming growth factor-β gene transcription. J Biol Chem 271:15237–15243 Du XL, Edelstein D, Rossetti L, Fantus IG, Goldeberg H, Ziyadeh F, Wu J, Brownlee M (2000) Hyperglycemia-induced mithocondrial superoxide overproduction activates the exosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 97:12222–12226 McClain DA, Lubas WA, Cooksy RC, Hazel M, Parker GJ, Love DC, Hanover JA (2002) Altereted glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc Natl Acad Sci USA 99:10695–10699 Patti ME, Virkamaki A, Landaker EJ, Kanh CR, Yki-Jarvinen H (1999) Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling event in skeletal muscle. Diabetes 48: 1562–1571 Walgren JL, Vincent TS, Schey KL, Buse MG (2003) High glucose and insulin promote O-GlcNac modification of proteins, including α-tubulin. Am J Physiol Endocr Metab 284:E424–E434 Goldeberg HJ, Whiteside CI, Hart GH, Fantus IG (2006) Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen Activator Inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells. Endocrinology 147:222–231 Zachara NE, Hart GW (2006) Cell signaling, the essential role of O-GlcNAc! Biochim Biophys Acta 1761:599–617 Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M (2001) Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108:1341–1348 Federici M, Menghini R, Mauriello A, Hribal ML, Ferrelli F, Lauro D, Sbraccia P, Spagnoli LG, Sesti G, Lauro R (2002) Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation 106:466–472 Musicki B, Kramer MF, Beker RE, Burnett AL (2005) Inactivation of phosphorylated endothelail nitric oxide synthase (Ser-1177) by O-GlcNAc in 37 diabetes- associated erectile dysfunction. Proc Natl Acad Sci USA 102:11870–11875 Daniels MC, Kansal P, Smith TM, Paterson AJ, Kudlow JE, McClain DA (1993) Glucose regulation of transforming growth factor-alpha expression is mediated by products of the exosamine biosynthesis pathway. Mol Endocrinol 7:1041–1048 Gabriely I, Yang XM, Cases JA, Ma XH, Rossetti L, Barzilai N (2002) Hyper glycemia induces PAI-1 gene expression in adipose tissue by activation of the hexosamine biosynthetic pathway. Atherosclerosis 160:115–122 Goldeberg HJ, Scholey J, Fantus IG (2000) Glucosamine activates the plasminogen activator inhibitor -1 gene promoter throught Sp1 DNA binding sites in glomerular mesangial cells. Diabetes 49:863–871 Goldeberg HJ, Whiteside CI, Fantus IG (2002) The exosamine pathway regulates the plasminogen activator inhibitor-1 gene promoter and Sp1 transcriptional activation throught protein kinase C-beta I and delta. J Biol Chem 277:33833–33841 Kolm-Litty V, Sauer U, Nerlich A, Lehmann R, Schleicher ED (1998) High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest 101:160–169 Weigert C, Brodbeck K, Staiger H, Kausch C, Machicao F, Häring H, Schleicher ED (2004) Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB. J Biol Chem 279:23942–23952 Graier WF, Wascher TC, Lackner L, Toplak H, Krejs GJ, Kukovetz WR (1993) Exposure to elevated d-glucose concentrations modulates vascular endothelial cell vasodilatatory response. Diabetes 42:1497–1505 Oyadomari S, Gotoh T, Aoyagi K, Araki E, Shichiri M, Mori M (2001) Coinduction of endothelial nitric oxide synthase and arginine recycling enzymes in aorta of diabetic rats. Nitric Oxide Biol Chem 5:252–260 Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA, Simonson DC, Creager MA (1998) Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97:1695–1701 Brodsky SV, Morrishow AM, Dharia N, Gross SS, Goligorsky MS (2001) Glucose scavenging of nitric oxide. Am J Physiol Renal Physiol 280:F480–F486 Graier WF, Posch K, Fleischhacker E, Wascher TC, Kostner GM (1999) Increased superoxide anion formation in endothelial cells during hyperglycemia: an adaptive response or initial step of vascular dysfunction? Diabetes Res Clin Pract 45:153–160 Cosentino F, Eto M, De Polis P, van der Loo B, Bachschmid M, Ullrich V, Kouroedov A, Delli Gatti C, Joch H, Volpe M, Lüscher TF (2003) High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells. Role of protein kinase C and reactive oxygen species. Circulation 107:1017–1023 Cosentino F, Hishikawa K, Katusic Z, Luscher TF (1997) High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96:25–28 Kojda G, Harrison D (1999) Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 43:652–571 Peng HB, Libby P, Liao JK (1995) Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem 270:14214–14219 Katsuyama K, Shichiri M, Marumo F, Hirata Y (1998) NO inhibits cytpkine-induced iNOS expression and NF-kappaB activation by interfering with phpsphorylation and degradation of IkappaB-alpha. Arterioscler Thromb Vasc Biol 18:1796–1802 Lander HM, Ogiste JS, Teng KK, Novogrodsky A (1995) p21 ras as a common signaling target of reactive free radicals and cellular redox stress. J Biol Chem 270:21195–21198 Du XL, Stocklauser-Farber K, Rosen P (1999) Generation of reactive oxygen intermediates, activation of NF-kappaB, and induction of apoptosis in human endothelial cells by glucose: role on nitric oxide synthase? Free Radic Biol Med 27:752–763 Sobrevia L, Mann GE (1997) Dysfunction of the endothelial nitric oxide signaling pathway in diabetes and hyperglycemia. Exp Physiol 82:423–452 Sobrevia L, Yudilevich DL, Mann GE (1998) Elevated d-glucose induces insulin insensitivity in human umbilical endothelial cells isolates from gestational diabetic pregnancies. J Physiol 506:219–230 Vasquez G, Sanhueza F, Vasquez R, Gonzalez M, SanMartýn R, Casanello P, Sobrevia L (2004) Role of adenosine transport in gestational diabetes-induced l-arginine transport and nitric oxide synthesis in human umbilical vein endothelium. J Physiol 560:111–122 Luoma JS, Stralin P, Marklund SL, Hiltunen TP, Sarkioja T, Yla-Herttuala S (1998) Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesion. Arterioscler Thromb Vasc Biol 18:157–167 Trovati M, Massucco P, Mattiello L, Costamagna C, Aldieri E, Cavalot F, Anfossi G, Bosia A, Ghigo D (1999) Human vascular smooth muscle cells express a costitutive nitric oxide synthase that insulin rapidly activates, thus increasing guanosine-3′,5′-cyclic monophosphate and adenosine-3′,5′-cyclic monophosphate concentrations. Diabetologia 42:831–839 Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T (2001) Mechanisms underlaying endothelial dysfunction in diabetes mellitus. Circ Res 88:14–e22 Sugimoto H, Shikata K, Matsuda M, Kushiro M, Hayashi Y, Hiragushi K, Wada J, Makino H (1998) Increased expression of endothelial nitric oxide sinthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic retinopathy. Diabetologia 41:1426–1434 Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801–809 Bochaton-Piallat ML, Ropraz P, Gabbiani F, Gabbiani G (1996) Phenotypic heterogeneity in rat smooth muscle cell clones. Arterioscler Thromb Vasc Biol 16:815–820 Frid MG, Moiseeva EP, Stenmark KR (1994) Multiple phenotypically distinct smooth muscle cell population exist in the adult and developing bovine pulmonary arterial media in vivo. Circ Res 75:669–681 Klemm DJ, Watson PA, Frid MG et al (2001) cAMP response element-binding protein content is a molecular determinant of smooth muscle cell proliferation and migration. J Biol Chem 276:46132–46141 Kuro-o M, Nagai R, Nakahara K, Katoh H, Tsai RC, Tsuchimochi H, Yazaki Y, Ohkubo A, Takaku F (1991) cDNA cloning of a myosin heavy chain isoform in embrionic smooth muscle and its expression during vascular development and arterioscerosis. J Biol Chem 266:3768–3773 Mosse PR, Campbell GR, Wang ZL, Capbell YH (1985) Smooth Muscle phenotypic expression in human carotid arteries. I. Comparison of cells with diffuse intimal thicknings adjacent to atheromatous plaques with those of the media. Lab Invest 53:556–562 Rocnik E, Saward L, Pickering JG (2001) HSP47 expression by smooth muscle cells increased during arterial development and lesion formation is inhibited by fibrillar collagen. ArteriosclerThromb Vasc Biol 21:40–46 Owens GK (1995) Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75:487–517 Regan CP, Adam PJ, Madsen CS, Owens GK (2000) Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury. J Clin Invest 106:1139–1147 Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Cayatte AJ, Rozek MM (1992) Pathogenesis of the atherosclerotic lesion. Implications for diabetes mellitus. Diabetes Care 15:1156–1167 Kansaki T, Shinomiya M, Ueda S, Morisaki N, Saito Y, Yoshida S (1994) Enhanced arterial intimal thickening after balloon catheter injury in diabetic animals accompanied by PDGF alfa- receptor overexpression of aortic media. Eur J Clin Invest 24:377–381 Moreno PR, Fallon JT, Murcia AM, Leon MN, Simosa H, Fuster V, Palacios IF (1999) Tissue characteristics of restenosis after percutaneus transluminal coronary angioplasty in diabetic patiens. J Am Coll Cardiol 34:1045–1049 Watson PA, Nesterova A, Burant CF, Klemm J, Reush JE-B (2001) Diabetes- related changes in cAMP response element- binding protein content enhance smooth muscle cell proliferation and migration. J Biol Chem 276:46142–46150 Suzuki LA, Poot M, Gerrity RG, Bornfeldt KE (2001) Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis. Diabetes 50:851–860 Faries Pl, Rohan DI, Takahara H, Wyers MC, Contreras MA, Quist WC, King GL, Logerfo FW (2001) Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration. J Vasc Surg 33:601–607 Pagano PJ (2001) NAD(P)H oxidase. Marker of the differentiated neointimal smooth muscle cell? Arterioscler Thromb Vasc Biol 21:175–177 West NEJ, Guzik J, Black E, Channon KM (2001) Enhanced superoxide production in experimental venous bypass graft intimal hyperplasia. Role of NAD(P)H oxidase. ArteriosclerThromb Vasc Biol 21:189–194 Cosentino F, Luscher T (1998) Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol 32:S54–S61 Felaco M, Grilli A, De Lutiis MA, Patruno A, Libertini N, Taccardi AA, Di Napoli P, Di Giulio C, Barbacane R, Conti P (2001) Endothelial nitric oxide synthase (eNOS) expression and localization in healthy and diabetic rat hearts. Ann Clin Lab Sci 31:179–186 Graier WF, Simecek S, Kukovetz WR, Kostner GM (1996) High d-glucose-induced changes in endothelial Ca2+/EDRF signaling are due to generation of superoxide anions. Diabetes 45:1386–1395 Okuda Y, Kawashima K, Sawada T, Tsurumaru K, Asano M, Suzuki S, Soma M, Nakajima T, Yamashita K (1997) Eicosapentaenoic acid enhanced nitric oxide production by cultured human endothelial cells. Biochem Biophys Res Commun 232:487–491 Pieper GM, Dondlinger L (1997) Glucose elevations alter bradykinin- stimulated intracellular calcium accumulation in cultured endothelial cells. Cardiovasc Res 34:169–178 Sobrevia L, Nadal A, Yudilevich DL, Mann GE (1996) Activation of l- arginine transport system (y+) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells. J Physiol 490:775–781 Chakravarthy U, Hayes RG, Stitt AW, McAuley E, Archer DB (1998) Constitutive Nitric Oxide Synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. Diabetes 47:945–942 Etienne P, Pares-Herbute N, Mani-Ponset L et al (1998) Phenotype modulation in primary cultures of aortic smooth muscle cells from streptozotocin-diabetic rats. Differentiation 63:225–236 Sharpe PC, Liu WH, Yue KK, McMaster D, Catherwood MA, McGinty AM, Trimble ER (1998) Glucose- induced oxidative stress in vascular contractile cells. Comparison of aortic smooth muscle cells and retinal pericytes. Diabetes 47:801–809 Pagano PJ, Haurani MJ (2006) Vascular cell locomotion: osteopontin, NADPH Oxidase, and matrix metalloproteinase-9. Circ Res 98:1453–1455 Thomas SR, Chen K, Keaney JF (2002) Hydrogen peroxide activates endothelial nitric oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-Kinase- dependent signaling pathway. J Biol Chem 277:6017–6024 Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327–334 Consoli A, Di Tomo P, Giardinelli A, Di Silvestre S, Patrono A, Grilli A, Capani F, Felaco M, Pandolfi A (2004) Inducile Nitric Oxide Synthase (iNOS) activity is increased in vascular smooth muscle cells (vSMC) from thoracic oarta of diabetic rats. Diabetologia 47:A87 (Abstract) Nagareddy PR, Xia Z, McNeill JH, MacLeod KM (2005) Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am J Physiol Heart Circ Physiol 289:H2144–H2152 Boulanger CM, Heymes C, Benessiano J, Geske RS, Lévy BI, Vanhoutte PM (1998) Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells. Activation by Angiotensin II in hypertension. Circ Res 83:1271–1278 Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F (2005) Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Eur J Pharmacol 511:53–64 Cai S, Khoo J, Mussa S, Alp NJ, Channon KM (2005) Endothelial nitric oxide synthase dysfunction in diabetic mice: importance of tetrahydrobiopterin in eNOS dimerisation. Diabetologia 48:1933–1940 Wolin MS, Davidson CA, Kaminski PM, Fayngersh RP, Mohazzab-H KM (1998) Oxidant-nitric oxide signaling mechanisms in vasculr tissue. Biochemistry (Mosc) 63:810–816 (Review) Etienne P, Pares-Herbutè N, Monnier L (1996) Enhanced antiproliferative effect of nitric oxide in cultured smooth muscle cells from diabetic rats. J Cardiovasc Pharmacol 27:140–146 Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135–1143 Basta G, Schmidt AM, De Caterina R (2004) Advanced glycation end products and vascular inflammation: implication for accetarated atherosclerosis in diabetes. Cardiovasc Res 63:582–592 Ajani UA, Ford ES, Mokdad AH (2004) Dietary fiber and C-reactive protein: findings from national healt and nutrition examination survey data. J Nutr 134:1181–1185 King DE, Egan BM, Geesey ME (2003) Relation of dietary fat and fier to elevation of C-reactive protein. Am J Cardiol 92:1335–1339 Qi L, van Dam RM, Liu S, Franz M, Mantzoros C, Hu FB (2006) Whole- grain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women. Diabetes Care 29:207–211